Beiersdorf   Report issue

For profit Phase 3
Founded: Hamburg Germany (1882)
Status: No NME R&D (1882)

Organization Overview

First Clinical Trial
2018
NCT03610386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beiersdorf | Beiersdorf (Thailand) Co., Ltd.

Active Ingredients

Drugs in Phase 3 Trials (1)

isobutylamido-thiazolyl-resorcinol (Thiamidol) (1 trial)

Drugs in Other Trials (1)

menthoxypropanediol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Facies (Phase 3)

Hyperpigmentation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2